CD4 and myeloid sarcoma: In contrast, the MS group showed significantly increased scores for MPP (HSC), astrocytes, preadipocytes (stroma and epithelial), aDC, B cells, CD4+ memory T cells, CD4+ Tem, CD8+ Tcm, cDC, DC, M1/M2 macrophages, mast cells, monocytes, NK cells, pDC, and Th2 cells (immune cells) (all P<0.05).